StreetInsider.com News Articles

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

Thu, 13 Aug 2026 07:00:00 -0400

ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug 26^th as part of the CEO spotlight event.

The Georgia Life Sciences Summit brings together leaders from across biotechnology, medical technology, research, manufacturing, and investment to showcase Georgia’s emergence as a national leader in life sciences innovation.

The Summit takes place on Aug 25-26 at the Sandy Springs Performing Arts Centre located at 1 Galambos Way, Sandy Springs, Georgia.

About AVERSA™ Abuse-Deterrent Transdermal Technology

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

Thu, 13 Aug 2026 07:00:00 -0400

The Summit takes place on Aug 25-26 at the Sandy Springs Performing Arts Centre located at 1 Galambos Way, Sandy Springs, Georgia.

About AVERSA™ Abuse-Deterrent Transdermal Technology

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

Thu, 13 Aug 2026 07:00:00 -0400

The Summit takes place on Aug 25-26 at the Sandy Springs Performing Arts Centre located at 1 Galambos Way, Sandy Springs, Georgia.

About AVERSA™ Abuse-Deterrent Transdermal Technology

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight

Thu, 13 Aug 2026 07:00:00 -0400

The Summit takes place on Aug 25-26 at the Sandy Springs Performing Arts Centre located at 1 Galambos Way, Sandy Springs, Georgia.

About AVERSA™ Abuse-Deterrent Transdermal Technology

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Fri, 15 May 2026 07:00:00 -0400

Nutriband’s Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers

ORLANDO, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) and its wholly owned subsidiary Active Intelligence (“Active Intelligence” or the “Company”), an emerging leader in innovative wellness, recovery, and performance-focused consumer products, today announced its participation in the upcoming ECRM conference taking place in June 2026, where the Company will showcase its latest AI-branded product portfolio to

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Fri, 15 May 2026 07:00:00 -0400

Nutriband’s Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Fri, 15 May 2026 07:00:00 -0400

Nutriband’s Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Fri, 15 May 2026 07:00:00 -0400

Nutriband’s Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Fri, 15 May 2026 07:00:00 -0400

Nutriband’s Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Fri, 15 May 2026 07:00:00 -0400

Nutriband’s Active Intelligence subsidiary to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Company to Meet with Buyers from Walmart Inc, Walgreens, Amazon.com, Inc., Cardinal Health and Other Major National Retailers

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

Wed, 22 Apr 2026 07:00:00 -0400

ORLANDO, Fla., April 22, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan has featured on the latest episode of the Jack Neel Podcast to discuss the opioid crisis, the Company’s AVERSA technology and the opportunity for Nutriband to improve the safety profile of easily abused medications.

Interested shareholders may find the link to the latest youtube episode here https://youtu.be/HB6E7TxGXqg?si=VU6c57saNbdzxraH.

The Episode can also be found on Spotify, iTunes, Amazon music and www.jackneel.com

About AVERSA™ Abuse-Deterrent Transdermal Technology

Nutriband's AVERSA™ abuse-deterrent

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

Wed, 22 Apr 2026 07:00:00 -0400

Interested shareholders may find the link to the latest youtube episode here https://youtu.be/HB6E7TxGXqg?si=VU6c57saNbdzxraH.

The Episode can also be found on Spotify, iTunes, Amazon music and www.jackneel.com

About AVERSA™ Abuse-Deterrent Transdermal Technology

Nutriband's AVERSA™ abuse-deterrent

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

Wed, 22 Apr 2026 07:00:00 -0400

Interested shareholders may find the link to the latest youtube episode here https://youtu.be/HB6E7TxGXqg?si=VU6c57saNbdzxraH.

The Episode can also be found on Spotify, iTunes, Amazon music and www.jackneel.com

About AVERSA™ Abuse-Deterrent Transdermal Technology

Nutriband's AVERSA™ abuse-deterrent

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

Wed, 22 Apr 2026 07:00:00 -0400

Interested shareholders may find the link to the latest youtube episode here https://youtu.be/HB6E7TxGXqg?si=VU6c57saNbdzxraH.

The Episode can also be found on Spotify, iTunes, Amazon music and www.jackneel.com

About AVERSA™ Abuse-Deterrent Transdermal Technology

Nutriband's AVERSA™ abuse-deterrent

Nutriband selects brand name for abuse deterrent fentanyl patch

Mon, 30 Mar 2026 16:05:54 -0400

Nutriband Inc. (NASDAQ: NTRB) announced it has selected a commercial brand name for its abuse deterrent fentanyl transdermal system and will submit the name to the FDA for approval along with product labeling.

The Orlando-based pharmaceutical company partnered with Brand Institute Inc. to develop the worldwide commercial brand name and visual identity for the product. Brand Institute specializes in pharmaceutical and healthcare-related brand name development and has been responsible for 75% of drug name approvals globally, including 87% of FDA approved names in 2024.

Nutriband's fentanyl patch incorporates the company's AVERSA abuse deterrent transdermal technology, which uses aversive agents to prevent abuse,

Nutriband selects brand name for abuse deterrent fentanyl patch

Mon, 30 Mar 2026 16:05:54 -0400

Nutriband's fentanyl patch incorporates the company's AVERSA abuse deterrent transdermal technology, which uses aversive agents to prevent abuse,

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Mon, 30 Mar 2026 16:05:00 -0400

Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit to the FDA for approval per FDA Guidance.

Nutriband partnered with Brand Institute, Inc, the global leader in pharmaceutical and healthcare-related brand name and identity development.

ORLANDO, Fla., March 30, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has selected the commercial worldwide brand name candidate for its lead product, an abuse deterrent fentanyl transdermal system. The proposed brand name and

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Mon, 30 Mar 2026 16:05:00 -0400

Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit to the FDA for approval per FDA Guidance.

Nutriband partnered with Brand Institute, Inc, the global leader in pharmaceutical and healthcare-related brand name and identity development.

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Mon, 30 Mar 2026 16:05:00 -0400

Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit to the FDA for approval per FDA Guidance.

Nutriband partnered with Brand Institute, Inc, the global leader in pharmaceutical and healthcare-related brand name and identity development.

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Mon, 30 Mar 2026 16:05:00 -0400

Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit to the FDA for approval per FDA Guidance.

Nutriband partnered with Brand Institute, Inc, the global leader in pharmaceutical and healthcare-related brand name and identity development.

Nutriband receives Costa Rica approval for kinesiology tapes

Wed, 18 Mar 2026 07:03:08 -0400

Nutriband Inc. (NASDAQ: NTRB) announced that Costa Rica's Ministry of Health has approved the company's kinesiology tapes for import and sale in the country. The regulatory approval was overseen and financed by Innomedica CCB S.A., Nutriband's exclusive distribution partner for Costa Rica.

The Orlando-based company stated it plans to increase marketing efforts for the kinesiology products and its mosquito repellent patch line following the approval. Nutriband previously announced an exclusive distribution agreement with Innomedica for its kinesiology line, AVERSA products, and mosquito repellent patches.

Nutriband develops transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch that incorporates the company's

Nutriband receives Costa Rica approval for kinesiology tapes

Wed, 18 Mar 2026 07:03:08 -0400

Nutriband develops transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch that incorporates the company's

Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica

Wed, 18 Mar 2026 07:00:00 -0400

The Company recently announced an exclusive distribution agreement with Innomedica CCB S.A. for its Kinesiology Line, AVERSA products and Mosquito repellent patches

ORLANDO, Fla., March 18, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) today announced that The Costa Rica Ministry of Health has approved the Company’s line of Kinesiology Tapes for import and Sale. Innomedica CCB, the company’s exclusive distribution partner for Costa Rica oversaw and financed the regulatory approval process.

The Company, partnering with Innomedica plans to begin ramping up marketing efforts for these products and its mosquito repellant patch line following this latest

Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica

Wed, 18 Mar 2026 07:00:00 -0400

The Company recently announced an exclusive distribution agreement with Innomedica CCB S.A. for its Kinesiology Line, AVERSA products and Mosquito repellent patches

The Company, partnering with Innomedica plans to begin ramping up marketing efforts for these products and its mosquito repellant patch line following this latest

Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica

Wed, 18 Mar 2026 07:00:00 -0400

The Company recently announced an exclusive distribution agreement with Innomedica CCB S.A. for its Kinesiology Line, AVERSA products and Mosquito repellent patches

The Company, partnering with Innomedica plans to begin ramping up marketing efforts for these products and its mosquito repellant patch line following this latest